Back to Search
Start Over
Genentech Reports Promising Phase II Results with New Targeted Approach in Advanced Melanoma
- Source :
- Business Wire. November 4, 2010
- Publication Year :
- 2010
-
Abstract
- New Data on Inhibition of Advanced BRAF Mutated Melanoma SOUTH SAN FRANCISCO, Calif. -- Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.241311180